Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged writ of mandamus · clear
MYLAN LABS. LTD. v. JANSSEN PHARMACEUTICA, N.V. Before Newman, Moore, and Stoll. Appeal from the Patent Trial and Appeal Board. Summary: The Federal Circuit lacks jurisdiction over appeals from decisions denying institution of an IPR. However, the Federal…
Federal Circuit Summary Before O’Malley, Bryson , and Chen. Appeal from the Patent Trial and Appeal Board. Summary : A writ of mandamus cannot be used as an alternative means of obtaining appellate review of institution decisions in IPRs, since…
Federal Circuit Summary Before PROST , WALLACH, and TARANTO. On Petition for Writ of Mandamus to the U.S. District Court for the District of Delaware. Summary : The patent venue statute, 28 U.S.C. § 1400(b), does not apply to foreign corporations,…
